|
Volumn 39, Issue 10, 2000, Pages 1330-1333
|
Genetics of childhood disorders: XIX. ADHD, Part 3: Is ADHD a noradrenergic disorder?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE;
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
AMFEBUTAMONE;
AMITRIPTYLINE;
ATOMOXETINE;
BUSPIRONE;
CLONIDINE;
DESIPRAMINE;
GUANFACINE;
IMIPRAMINE;
METHYLPHENIDATE;
MONOAMINE OXIDASE INHIBITOR;
NORADRENALIN;
NORTRIPTYLINE;
PROTRIPTYLINE;
TERTIARY AMINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VENLAFAXINE;
ATTENTION DEFICIT DISORDER;
CHILD;
CHILDHOOD DISEASE;
CLINICAL TRIAL;
DOPAMINERGIC SYSTEM;
DRUG EFFICACY;
GENETIC DISORDER;
HUMAN;
NEUROPSYCHOLOGY;
NEUROTRANSMISSION;
NORADRENERGIC SYSTEM;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
SEROTONIN METABOLISM;
SHORT SURVEY;
SUSTAINED RELEASE PREPARATION;
|
EID: 0033818549
PISSN: 08908567
EISSN: None
Source Type: Journal
DOI: 10.1097/00004583-200010000-00024 Document Type: Short Survey |
Times cited : (27)
|
References (8)
|